Skip to main content
رجوع
Watch Compare

Benitec Biopharma Inc.

جودة البيانات: 83%
BNTC
Nasdaq Manufacturing Chemicals
KWD 11.01
▼ KWD 0.05 (-0.45%)
القيمة السوقية: 377.15 M
السعر
KWD 11.01
القيمة السوقية
377.15 M
نطاق اليوم
KWD 10.56 — KWD 11.10
نطاق 52 أسبوعًا
KWD 9.85 — KWD 17.15
حجم التداول
53,859
فتح KWD 10.89
متوسط 50 يوم / 200 يوم
KWD 11.40
3.42% below
متوسط 50 يوم / 200 يوم
KWD 12.74
13.60% below

Quick Summary

النقاط الرئيسية

Negative free cash flow of -26.16 M

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-38.20%
أعلى من متوسط القطاع (-51.02%)
ROIC-33.16%
Net MarginN/A
Op. MarginN/A

الأمان

Debt / Equity
N/A
Current Ratio67.69
Interest CoverageN/A

التقييم

PE (TTM)
-7.03
أقل من متوسط القطاع (-1.98)
P/B Ratio2.01
EV/EBITDAN/A
Dividend YieldN/A

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Manufacturing (44 نظير)
المقياس السهم وسيط القطاع
P/E -7.0 -2.0
P/B 2.0 5.1
ROE % -38.2 -51.0
Net Margin % — -150.2
Rev Growth 5Y % — 9.3
D/E — 0.3

ETFs Holding This Stock

PINK logo PINK Simplify Health Care ETF
0.62% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -53.66 M
ROE -38.20% ROA -37.43%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -26.16 M
ROIC -33.16% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 67.69
Interest Coverage N/A Asset Turnover N/A
Working Capital 186.79 M Tangible Book Value 187.36 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -7.03 Forward P/E N/A
P/B Ratio 2.01 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -6.94%
Market Cap 377.15 M Enterprise Value 188.36 M
Per Share
EPS (Diluted TTM) -1.05 Revenue / Share N/A
FCF / Share -0.76 OCF / Share -0.76
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 48.75%
SBC-Adj. FCF -42.69 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — 59,000.0
Net Income -37.92 M -21.75 M -19.56 M -18.21 M -13.88 M
EPS (Diluted) -1.05 -5.51 -14.12 -2.23 —
Gross Profit — — — — —
Operating Income -41.77 M -22.49 M -19.08 M -17.85 M -13.60 M
EBITDA — — — — —
R&D Expenses 18.33 M 15.61 M 12.77 M 11.27 M 7.02 M
SG&A Expenses — — — — —
D&A 66,000.0 87,000.0 136,000.0 167,000.0 231,000.0
Interest Expense — — — — —
Income Tax — — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 99.59 M 52.21 M 4.46 M 5.97 M 21.38 M
Total Liabilities 2.30 M 4.96 M 4.26 M 3.09 M 1.37 M
Shareholders' Equity 97.30 M 47.25 M 202,000.0 2.88 M 20.01 M
Total Debt — — — — —
Cash & Equivalents 97.74 M 50.87 M 2.48 M 4.06 M 19.77 M
Current Assets 98.52 M 51.67 M 3.73 M 4.82 M 20.61 M
Current Liabilities 1.80 M 4.92 M 3.98 M 2.53 M 1.37 M